Neurochemical alteration in the caudate: Implications for the pathophysiology of bipolar disorder

Psychiatry Research - Neuroimaging

Volumn 193, Issue 2, 2011, Pages 107-112

  Shahana, Nasrin ^a   DelBello, Melissa ^a   Chu, Wen Jang ^b   Jarvis, Kelly ^a   Fleck, David ^a,b   Welge, Jeffrey ^a   Strakowski, Stephen ^a,b   Adler, Caleb ^a,b  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF CINCINNATI   (United States)

Author keywords

Bipolar disorder; Caudate; Imaging; Magnetic resonance spectroscopy

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; CHOLINE; CHROMIUM; NEUROTRANSMITTER;

ADULT; AGE; ARTICLE; BIPOLAR DISORDER; CAUDATE NUCLEUS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENDER; GRAY MATTER; HUMAN; MALE; NEUROIMAGING; NEUROTRANSMISSION; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RATING SCALE; WHITE MATTER;

ADOLESCENT; ADULT; ANTIDEPRESSIVE AGENTS; ASPARTIC ACID; BIPOLAR DISORDER; BRAIN MAPPING; CAUDATE NUCLEUS; CHOLINE; CREATINE; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MALE; YOUNG ADULT;

EID: 79959739055     PISSN: 09254927     EISSN: 18727506     Source Type: Journal    
DOI: 10.1016/j.pscychresns.2011.01.014     Document Type: Article

References (43)

1. Alexander G.E., DeLong M.R., Strick P.L. Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Annual Review of Neuroscience 1986, 9:357-381.
2. Alexander G.E., Crutcher M.D., DeLong M.R. Basal ganglia-thalamocortical circuits: parallel substrates for motor, oculomotor, "prefrontal" and "limbic" functions. Progress in Brain Research 1990, 85:119-146.
3. Atmaca M., Yildirim H., Ozdemir H., Ogur E., Tezcan E. Hippocampal 1H MRS in patients with bipolar disorder taking valproate versus valproate plus quetiapine. Psychological Medicine 2007, 37:121-129.
4. Aylward E.H., Roberts-Twillie J.V., Barta P.E., Kumar A.J., Harris G.J., Geer M., Peyser C.E., Pearlson G.D. Basal ganglia volumes and white matter hyperintensities in patients with bipolar disorder. The American Journal of Psychiatry 1994, 151:687-693.
5. Azizian A., Monterosso J., O'Neill J., London E.D. Magnetic resonance imaging studies of cigarette smoking. Handbook of Experimental Pharmachology 2009, 192:113-143.
6. Blumberg H.P., Stern E., Martinez D., Ricketts S., de Asis J., White T., Epstein J., McBride P.A., Eidelberg D., Kocsis J.H., Silbersweig D.A. Increased anterior cingulate and caudate activity in bipolar mania. Biological Psychiatry 2000, 48:1045-1052.
7. Buchsbaum M.S., Wu J., DeLisi L.E., Holcomb H., Kessler R., Johnson J., King A.C., Hazlett E., Langston K., Post R.M. Frontal cortex and basal ganglia metabolic rates assessed by positron emission tomography with [18F]2-deoxyglucose in affective illness. Journal of Affective Disorder 1986, 10:137-152.
8. Chang K., Adleman N.E., Dienes K., Simeonova D.I., Menon V., Reiss A. Anomalous prefrontal-subcortical activation in familial pediatric bipolar disorder: a functional magnetic resonance imaging investigation. Archives of General Psychiatry 2004, 61:781-792.
9. Chu W.J., Kuzniecky R.I., Hugg J.W., Abou-Khalil B., Gilliam F., Faught E., Hetherington H.P. Statistically driven identification of focal metabolic abnormalities in temporal lobe epilepsy with corrections for tissue heterogeneity using 1H spectroscopic imaging. Magnetic Resonance in Medicine 2000, 43:359-367.
10. Dager S.R., Friedman S.D., Parow A., Demopulos C., Stoll A.L., Lyoo I.K., Dunner D.L., Renshaw P.F. Brain metabolic alterations in medication-free patients with bipolar disorder. Archives of General Psychiatry 2004, 61:450-458.
11. DelBello M.P., Zimmerman M.E., Mills N.P., Getz G.E., Strakowski S.M. Magnetic resonance imaging analysis of amygdala and other subcortical brain regions in adolescents with bipolar disorder. Bipolar Disorders 2004, 6:43-52.
12. DelBello M.P., Cecil K.M., Adler C.M., Daniels J.P., Strakowski S.M. Neurochemical effects of olanzapine in first-hospitalization manic adolescents: a proton magnetic resonance spectroscopy study. Neuropsychopharmacology 2006, 31:1264-1273.
13. Durazzo T.C., Gazdzinski S., Banys P., Meyerhoff D.J. Cigarette smoking exacerbates chronic alcohol-induced brain damage: a preliminary metabolite imaging study. Alcoholism, Clinical and Experimental Research 2004, 12:1849-1860.
14. Ertugrul A., Ulug B. The effect of clozapine on neuroimaging findings in schizophrenia. Psychiatria Danubina 2007, 19:367-369.
15. Frye M.A., Thomas M.A., Yue K., Binesh N., Davanzo P., Ventura J., O'Neill J., Guze B., Curran J.G., Mintz J. Reduced concentrations of N-acetylaspartate (NAA) and the NAA-creatine ratio in the basal ganglia in bipolar disorder: a study using 3-Tesla proton magnetic resonance spectroscopy. Psychiatry Research: Neuroimaging 2007, 154:259-265.
16. Garwood M., DelaBarre L. The return of the frequency sweep: designing adiabatic pulses for contemporary NMR. Journal of Magnetic Resonance 2001, 153:155-177.
17. Gazdzinski S., Durazzo T.C., Yeh P.-H., Hardin D., Banys P., Meyerhoff D.J. Chronic cigarette smoking modulates injury and short-term recovery of the medial temporal lobe in alchoholics. Psychiatry Research: Neuroimaging 2008, 162:133-145.
18. Glitz D.A., Manji H.K., Moore G.J. Mood disorders: treatment-induced changes in brain neurochemistry and structure. Seminers in Clinical Neuropsychiatry 2002, 7:269-280.
19. Hamakawa H., Kato T., Murashita J., Kato N. Quantitative proton magnetic resonance spectroscopy of the basal ganglia in patients with affective disorders. European Archives of Psychiatry Clinical Neuroscience 1998, 248:53-58.
20. Hetherington H.P., Pan J.W., Mason G.F., Adams D., Vaughn M.J., Twieg D.B., Pohost G.M. Quantitative 1H spectroscopic imaging of human brain at 4.1T using image segmentation. Magnetic Resonance in Medicine 1996, 36:21-29.
21. Kato T., Hamakawa H., Shioiri T., Murashita J., Takahashi Y., Takahashi S., Inubushi T. Choline-containing compounds detected by proton magnetic resonance spectroscopy in the basal ganglia in bipolar disorder. Journal of Psychiatry & Neuroscience 1996, 21:248-254.
22. Krishnan K.R., Figiel G.S. Neurobehavioral changes with caudate lesions. Neurology 1989, 39:1410-1411.
23. Licata S.C., Renshaw P.F. Insights from proton magnetic resonance specteroscopic imaging and their relevance to addiction. Annals of the Newyork Academy of Sciences 2010, 1187:148-171.
24. Mega M.S., Cummings J.L. Frontal-subcortical circuits and neuropsychiatric disorders. The Journal of Neuropsychiatry and ClinIical Neuroscience 1994, 6:358-370.
25. Miller B.L., Chang L., Booth R., Ernst T., Cornford M., Nikas D., McBride D., Jenden D.J. In vivo 1H MRS choline: correlation with in vitro chemistry/histology. Life Sciences 1996, 58:1929-1935.
26. Miyasaka N., Takahashi K., Hetherington H.P. Fully automated shim mapping method for spectroscopic imaging of the mouse brain at 9.4T. Magnetic Resonance in Medicine 2006, 55:198-202.
27. Molina V., Sanchez J., Sanz J., Reig S., Benito C., Leal I., Sarramea F., Rebolledo R., Palomo T., Desco M. Dorsolateral prefrontal N-acetyl-aspartate concentration in male patients with chronic schizophrenia and with chronic bipolar disorder. European Psychiatry 2007, 22:505-512.
28. Moore G.J., Galloway M.P. Magnetic resonance spectroscopy: neurochemistry and treatment effects in affective disorders. Psychopharmacology Bulletin 2002, 36:5-23.
29. Ohara K., Isoda H., Suzuki Y., Takehara Y., Ochiai M., Takeda H., Igarashi Y. Proton magnetic resonance spectroscopy of the lenticular nuclei in bipolar I affective disorder. Psychiatry Research: Neuroimaging 1998, 84:55-60.
30. Ohrmann P., Siegmund A., Suslow T., Pedersen A., Spitzberg K., Kersting A., Rothermundt M., Arolt V., Heindel W., Pfleiderer B. Cognitive impairment and in vivo metabolites in first-episode neuroleptic-naive and chronic medicated schizophrenic patients: a proton magnetic resonance spectroscopy study. Journal of Psychiatric Research 2007, 41:625-634.
31. Parikh V., Khan M.M., Mahadik S.P. Differential effects of antipsychotics on expression of antioxidant enzymes and membrane lipid peroxidation in rat brain. Journal of Psychiatric Research 2003, 37:43-51.
32. Patel N.C., Cecil K.M., Strakowski S.M., Adler C.M., DelBello M.P. Neurochemical alterations in adolescent bipolar depression: a proton magnetic resonance spectroscopy pilot study of the prefrontal cortex. Journal of Child and Adolescent Psychopharmacology 2008, 18:623-627.
33. Pillai A., Parikh V., Terry A.V., Mahadik S.P. Long-term antipsychotic treatments and crossover studies in rats: differential effects of typical and atypical agents on the expression of antioxidant enzymes and membrane lipid peroxidation in rat brain. Journal of Psychiatric Research 2007, 41:372-386.
34. Regier D.A., Farmer M.E., Rae D.S., Locke B.Z., Keith S.J., Judd L.L., Goodwin F.K. Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study. The Journal of The American Medical Association 1990, 264:2511-2518.
35. Senaratne R., Milne A.M., MacQueen G.M., Hall G.B. Increased choline-containing compounds in the orbitofrontal cortex and hippocampus in euthymic patients with bipolar disorder: a proton magnetic resonance spectroscopy study. Psychiatry Research: Neuroimaging 2009, 172:205-209.
36. Sharma R., Venkatasubramanian P.N., Barany M., Davis J.M. Proton magnetic resonance spectroscopy of the brain in schizophrenic and affective patients. Schizophrenia Research 1992, 8:43-49.
37. Silverstone P.H., McGrath B.M., Kim H. Bipolar disorder and myo-inositol: a review of the magnetic resonance spectroscopy findings. Bipolar Disorders 2005, 7:1-10.
38. Soares J.C., Krishnan K.R., Keshavan M.S. Nuclear magnetic resonance spectroscopy: new insights into the pathophysiology of mood disorders. Depression 1996, 4:14-30.
39. Strakowski S.M., DelBello M.P., Sax K.W., Zimmerman M.E., Shear P.K., Hawkins J.M., Larson E.R. Brain magnetic resonance imaging of structural abnormalities in bipolar disorder. Archives of General Psychiatry 1999, 56:254-260.
40. Strakowski S.M., DelBello M.P., Adler C., Cecil D.M., Sax K.W. Neuroimaging in bipolar disorder. Bipolar Disorders 2000, 2:148-164.
41. Wessa M., Houenou J., Paillere-Martinot M.L., Berthoz S., Artiges E., Leboyer M., Martinot J.L. Fronto-striatal overactivation in euthymic bipolar patients during an emotional go/nogo task. The American Journal of Psychiatry 2007, 164:638-646.
42. Wu R.H., O'Donnell T., Ulrich M., Asghar S.J., Hanstock C.C., Silverstone P.H. Brain choline concentrations may not be altered in euthymic bipolar disorder patients chronically treated with either lithium or sodium valproate. Annals of General Psychiatry 2004, 3:13.
43. Yamasue H., Fukui T., Fukuda R., Kasai K., Iwanami A., Kato N., Kato T. Drug-induced parkinsonism in relation to choline-containing compounds measured by 1H-MR spectroscopy in putamen of chronically medicated patients with schizophrenia. The International Journal of Neuropsychopharmacology 2003, 6:353-360.